Safety issues relating to long‐term treatment with histamine H2‐receptor antagonists
@article{Sabesin1993SafetyIR, title={Safety issues relating to long‐term treatment with histamine H2‐receptor antagonists}, author={Seymour M. Sabesin}, journal={Alimentary Pharmacology \& Therapeutics}, year={1993}, volume={7} }
H2‐receptor antagonist therapy is associated with a low incidence of adverse reactions. Adverse events reported in clinical trials of ranitidine in daily doses of up to 1200 mg include headache, tiredness and mild gastrointestinal disturbances, but the incidence is similar to or less than that for placebo. High doses of cimetidine (> 5 g/day) can cause reversible impotence or gynaecomastia. While ranitidine exhibits no clinically significant drug‐drug interactions, cimetidine interacts with…
32 Citations
Proton pump inhibitors and cardiovascular adverse effects: Real or surreal worries?
- Medicine, BiologyEuropean journal of internal medicine
- 2019
High‐dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
- MedicineAlimentary pharmacology & therapeutics
- 1996
High dose ranitidine is effective for the prevention of recurrent duodenal ulcer but not for recurrent gastric ulcer in rheumatoid arthritis patients taking NSAIDs.
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
- MedicineJournal of investigational allergology & clinical immunology
- 2006
3 cases of anaphylactic reactions induced by lansoprazole or ranitidine diagnosed in a population of 8304 first-referral patients over a 13-year period are reported.
Pharmacogenomics for the efficacy and side effects of antihistamines
- Biology, MedicineExperimental dermatology
- 2022
Current reports in pharmacogenomics are summarized, aiming to contribute to future research in antihistamines and clinical guidance for antihistamine use in individualized medicine.
A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh
- MedicineToxicology reports
- 2022
Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease
- MedicineDigestive Diseases and Sciences
- 2017
Esophageal pH-impedance monitoring helps to distinguish functional heartburn from true GERD, and psychologic medication and cognitive behavior therapy are further therapy options instead of PPIs.
The safety of drugs used in acid-related disorders and functional gastrointestinal disorders.
- MedicineGastroenterology clinics of North America
- 2010
Side effects of drug treatments for gastro-oesophageal reflux disease: current controversies
- MedicineFrontline Gastroenterology
- 2020
A critical review of the published literature and the clinical significance of reported side effects of proton pump inhibitors and histamine-2 receptor antagonists in gastro-oesophageal reflux disease.
Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
- Biology, MedicineEcancermedicalscience
- 2014
It is proposed that cimetidine would synergise with a range of other drugs, including existing chemotherapeutics, and that further exploration of the potential ofcimetidine as an anti-cancer therapeutic is warranted.
Association Between Acid-Suppressive Agents’ Use and Risk of Hepatocellular Carcinoma
- MedicineDose-response : a publication of International Hormesis Society
- 2020
The use of AsAs increased the risk of HCC in patients with UGIDs, and the effect of ASAs was dose dependent, and in addition, UGID alone increased therisk of H CC.
References
SHOWING 1-10 OF 22 REFERENCES
Haematological Adverse Effects of Histamine H2-Receptor Antagonists
- Medicine, BiologyMedical toxicology and adverse drug experience
- 1988
Histamine H2-receptor antagonists are widely used in the treatment of gastrointestinal diseases related to gastric acid hypersecretion and may theoretically contribute to the occurrence of iron or cobalamin deficiency anaemia.
Safety profile of long‐term H2‐antagonist therapy
- MedicineAlimentary pharmacology & therapeutics
- 1991
The safety profile of low‐dose maintenance therapy with H2‐antagonists for duodenal ulcer disease suggests that these agents can be given safely for several years and probably much longer. Because…
The drug interaction potential of ranitidine: an update.
- Biology, MedicinePharmacology & therapeutics
- 1991
Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer.
- MedicineJournal of clinical gastroenterology
- 1985
At the doses prescribed, ranitidine was superior to cimetidine as maintenance therapy in duodenal ulcer disease and no significant drug-related adverse effects were seen with either drug during this 1 year trial.
Ranitidine at very large doses does not inhibit theophylline elimination
- Medicine, BiologyClinical pharmacology and therapeutics
- 1986
While case reports indicate ranitidine may inhibit theophylline metabolism specifically and drug metabolism in general, a controlled study was not able in this controlled study to detect any effect of ran itidine on theophyLLine elimination even at runningitidine doses up to fourteenfold greater than are generally prescribed.
10. Medical Events Occurring in Patients with Duodenal Ulcer Disease during Maintenance Treatment with Ranitidine
- Medicine
- 1990
Nausea, diarrhoea, and constipation were the most frequent complaints related to the gastrointestinal tract, but in most patients these symptoms were not related to treatment with ranitidine.
A study of the interaction of omeprazole and warfarin in anticoagulated patients.
- MedicineBritish journal of clinical pharmacology
- 1992
Patients on continuous therapy with warfarin were given omeprazole 20 mg once daily and placebo each for 3 weeks according to a two-centre randomised double-blind cross-over design and the anticoagulant effect was assessed using the Trombotest.
The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.
- Biology, MedicineBiochemical pharmacology
- 1982
Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach.
- MedicineMutation research
- 1991
Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers.
- MedicineGut
- 1991
Ranitidine 300mg at night abolishes the adverse effect of smoking observed during maintenance treatment with ranitidine 150 mg at night and may therefore be an appropriate maintenance dose for smokers who relapse during standard dose maintenance treatment.